Gene Editing Market: By Product, By Technology By Application By End- User and Region Forecast 2019-2030  

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Gene Editing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Reagents & Consumables, Software & Systems, Services), By Technology (CRISPR, TALEN, ZFN Others) By Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery & Development, Other) By End- User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations) and Region Forecast 2019-2030  

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Gene Editing Market size was valued at US$ 5,028.6 million in 2023 and is poised to grow at a significant CAGR of 16.1% from 2024-2030. Gene editing has shown potential in the therapy of genetic abnormalities, infectious illnesses, and cancer. Gene editing is a sort of genetic editing in which a DNA sequence is inserted, removed, or altered in an organism's genome to cure a specific condition using a designed nuclease or molecular scissor. The CRISPR segment is anticipated to grow at a significant CAGR over the forecast years owing to increased government and private investment, increased demand for and acceptance of CRISPR, and technology developments Individual investigator grants, government, and commercial enterprise, such as research projects and program awards that are projected to improve the market are frequently used to support the development of CRISPR technology. Continuous technological advancements in gene-editing tools is a major factor driving the growth of the market.

Gene Editing Market

Gene Editing Market Key Developments

  • In June 2021, Allele Biotechnology and Alpine BioTherapeutics Corporation announced an agreement for developing induced pluripotent stem cells for treatment of retinal diseases. This strategy assisted the company in developing advanced product portfolio.
  • In May 2020, Caribou Science entered into a commercial and clinical license agreement with MaxCyte. The deal was aimed to gain exclusive rights to use MaxCyte’s flow electroporation technology and the ExPERT platform. This is slated to advance Caribou’s gene-edited allogeneic T cell therapy programs and expand their corporate relations in the market.

summary download arrow Download Free Sample

Gene Editing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

16.1%

Largest Market

Asia Pacific

Fastest Growing Market

North America

Gene Editing Market Dynamics

Genome editing has shown promise in the treatment of genetic abnormalities, infectious illnesses, and cancer. Cancer and other hereditary disorders are becoming more widespread, and customised care is getting more popular. Many governments are increasing funding and grants to assist genome editing research in their countries/regions. Because of the advantages of genome editing, several governments are funding public and private research, as well as academic institutes, to expand genome editing and genetic engineering research. For instance, In March 2020, Genome Canada received USD 15 million from the Ministry of Innovation, Science, and Industry (Science) to fund 11 genomic research initiatives in the health, agricultural, and environment sectors. Provincial governments, industries, and research partners will contribute a total of USD 29.7 million to these research projects.

Gene Editing Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 5,028.6 million

Market CAGR

16.1%

By Product Type

  • Reagents & Consumables
  • Software & Systems
  • Services

By Technology

  • CRISPR
  • TALEN
  • ZFN
  • Others

By Application

  • Cell Line Engineering
  • Genetic Engineering
  • Diagnostic Applications
  • Drug Discovery & Development
  • Others

By End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The gene editing market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

Gene editing market size was valued at US$ 5,028.6 million in 2023 and is set to grow at a CAGR of 16.1% from 2024-2030.

CRISPR Therapeutics, Thermo Fisher Scientific, Inc., Integrated DNA Technologies, Inc.

The gene editing market segments are by product type, technology, application and end user

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Gene Editing Market Introduction
2.1. Global Gene Editing Market – Taxonomy
2.2. Global Gene Editing Market – Definitions
2.2.1. Product Type
2.2.2. Technology
2.2.3. Application
2.2.4. Region
3. Global Gene Editing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Current Trends
3.5. Global Gene Editing Market Dynamic Factors - Impact Analysis
3.6. Mergers, Acquisitions, and Collaborations
4. Global Gene Editing Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Gene Editing Market, By Product Type, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1. Reagents & Consumables
5.1.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis 
5.2. Software & Systems
5.2.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis 
5.3. Services
5.3.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis 
6. Global Gene Editing Market, By Technology, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1. CRISPR
6.1.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis 
6.2. TALEN
6.2.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis 
6.3. ZFN
6.3.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis 
6.4. Antisense
6.4.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Gene Editing Market, By Application, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1. Cell Line Engineering
7.1.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis 
7.2. Genetic Engineering
7.2.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis 
7.3. Diagnostic Applications
7.3.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis 
7.4. Drug Discovery & Development
7.4.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis 
8. Global Gene Editing Market, By End User, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1. Pharmaceutical and Biotechnology Companies
8.1.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis 
8.2. Academic and Research Institutes
8.2.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis 
8.3. Contract Research Organizations
8.3.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Gene Editing Market Forecast, By Region, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia Pacific
9.3.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. MEA
9.5.1. Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Gene Editing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and End User, and Country, 2024 - 2030
10. North America Gene Editing Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
10.1. Product Type Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Reagents & Consumables
10.1.2. Software & Systems
10.1.3. Services
10.2. Technology Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. CRISPR
10.2.2. TALEN
10.2.3. ZFN
10.2.4. Antisense
10.2.5. Others
10.3. Application Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Cell Line Engineering
10.3.2. Genetic Engineering
10.3.3. Diagnostic Applications
10.3.4. Drug Discovery & Development
10.3.5. Others
10.4. End User Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.4.1. Pharmaceutical and Biotechnology Companies
10.4.2. Academic and Research Institutes
10.4.3. Contract Research Organizations
10.5. Country Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.5.1. United States
10.5.2. Canada
10.6. North America Gene Editing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2024 - 2030
10.7. North America Gene Editing Market Dynamics – Trends
11. Europe Gene Editing Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
11.1. Product Type Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Reagents & Consumables
11.1.2. Software & Systems
11.1.3. Services
11.2. Technology Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. CRISPR
11.2.2. TALEN
11.2.3. ZFN
11.2.4. Antisense
11.2.5. Others
11.3. Application Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Cell Line Engineering
11.3.2. Genetic Engineering
11.3.3. Diagnostic Applications
11.3.4. Drug Discovery & Development
11.3.5. Others
11.4. End User Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.4.1. Pharmaceutical and Biotechnology Companies
11.4.2. Academic and Research Institutes
11.4.3. Contract Research Organizations
11.5. Country Level Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.5.1. UK
11.5.2. Germany
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Europe Gene Editing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2024 - 2030
11.7. Europe Gene Editing Market Dynamics – Trends
12. Asia Pacific Gene Editing Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
12.1. Product Type Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Reagents & Consumables
12.1.2. Software & Systems
12.1.3. Services
12.2. Technology Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. CRISPR
12.2.2. TALEN
12.2.3. ZFN
12.2.4. Antisense
12.2.5. Others
12.3. Application Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Cell Line Engineering
12.3.2. Genetic Engineering
12.3.3. Diagnostic Applications
12.3.4. Drug Discovery & Development
12.3.5. Others
12.4. End User Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.4.1. Pharmaceutical and Biotechnology Companies
12.4.2. Academic and Research Institutes
12.4.3. Contract Research Organizations
12.5. Country Level Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. ANZ
12.5.4. Japan
12.5.5. Rest of APAC
12.6. Asia Pacific Gene Editing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2024 - 2030
12.7. Asia Pacific Gene Editing Market Dynamics – Trends
13. MEA Gene Editing Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
13.1. Product Type Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Reagents & Consumables
13.1.2. Software & Systems
13.1.3. Services
13.2. Technology Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. CRISPR
13.2.2. TALEN
13.2.3. ZFN
13.2.4. Antisense
13.2.5. Others
13.3. Application Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Cell Line Engineering
13.3.2. Genetic Engineering
13.3.3. Diagnostic Applications
13.3.4. Drug Discovery & Development
13.3.5. Others
13.4. End User Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Pharmaceutical and Biotechnology Companies
13.4.2. Academic and Research Institutes
13.4.3. Contract Research Organizations
13.5. Country Level Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of MEA
13.6. MEA Gene Editing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2024 - 2030
13.7. MEA Gene Editing Market Dynamics – Trends
14. Latin America Gene Editing Market Analysis, 201 9 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
14.1. Product Type Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Reagents & Consumables
14.1.2. Software & Systems
14.1.3. Services
14.2. Technology Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. CRISPR
14.2.2. TALEN
14.2.3. ZFN
14.2.4. Antisense
14.2.5. Others
14.3. Application Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.3.1. Cell Line Engineering
14.3.2. Genetic Engineering
14.3.3. Diagnostic Applications
14.3.4. Drug Discovery & Development
14.3.5. Others
14.4. End User Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.4.1. Pharmaceutical and Biotechnology Companies
14.4.2. Academic and Research Institutes
14.4.3. Contract Research Organizations
14.5. Country Analysis 201 9 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.5.1. Brazil
14.5.2. Mexico
14.5.3. Argentina
14.5.4. Rest of LA
14.6. Latin America Gene Editing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2024 - 2030
14.7. Latin America Gene Editing Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Merck KGaA
15.2.2. Sangamo
15.2.3. Editas Medicine
15.2.4. Precision Biosciences
15.2.5. CRISPR Therapeutics
15.2.6. Intellia Therapeutics, Inc.
15.2.7. Caribou Biosciences, Inc.
15.2.8. Cellectis S.A.
15.2.9. AstraZeneca
15.2.10. Integrated DNA Technologies, Inc.
15.2.11. Egenesis Inc.
15.2.12. GenScript
15.2.13. OriGene Technologies, Inc.
15.2.14. Lonza
15.2.15. Thermo Fisher Scientific, Inc.
16. Research Methodology
17. Key Assumptions and Acronyms

Key Market Players

  • Merck KGaA
  • Sangamo
  • Editas Medicine
  • Precision Biosciences
  • CRISPR Therapeutics
  • Intellia Therapeutics, Inc
  • Caribou Biosciences, Inc.
  • Cellectis S.A.
  • AstraZeneca
  • Integrated DNA Technologies, Inc.
  • Egenesis Inc.
  • GenScript
  • OriGene Technologies, Inc.
  • Lonza
  • Thermo Fisher Scientific, Inc.

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market